NEUTROPEG pegfilgrastim 6 mg/0.6 mL solution for injection pre-filled syringe

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Beli sekarang

Laporan Penilaian Awam Laporan Penilaian Awam (PAR)
30-08-2019

Bahan aktif:

Pegfilgrastim, Quantity: 6 mg

Boleh didapati daripada:

Accord Healthcare Pty Ltd

Borang farmaseutikal:

Injection, solution

Komposisi:

Excipient Ingredients: glacial acetic acid; polysorbate 20; sodium hydroxide; sorbitol; water for injections

Laluan pentadbiran:

Subcutaneous

Unit dalam pakej:

1 prefilled syringe

Jenis preskripsi:

(S4) Prescription Only Medicine

Tanda-tanda terapeutik:

For the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and so reduce the incidence of infection, as manifested by febrile neutropenia.

Ringkasan produk:

Visual Identification: clear and colourless liquid; Container Type: Syringe; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status kebenaran:

Registered

Tarikh kebenaran:

2019-08-19